A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning-Reference-Cited by-同舟云学术

A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning

Published:2018-06-29 Issue:1 Volume:54 Page:168-172
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Osumi Tomoo,Tomizawa Daisuke^ORCID,Kawai Toshinao,Sako Mayumi,Inoue Eisuke,Takimoto Tetsuya,Tamura Eiichiro,Uchiyama Toru,Imadome Ken-Ichi,Taniguchi Maki,Shirai Ryota,Yoshida Masanori,Ando Rie,Tsumura Yusuke,Fuji Hiroshi,Matsumoto Kana,Shioda Yoko,Kiyotani Chikako,Terashima Keita,Onodera Masafumi,Matsumoto Kimikazu,Kato Motohiro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0271-9.pdf

Reference15 articles.

1. Winkelstein JA, Marino MC, Johnston RB Jr., Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.

2. Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;132:1150–5. https://doi.org/10.1016/j.jaci.2013.05.031 .

3. Segal BH, Veys P, Malech H, Cowan MJ. Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant. 2011;17(1 Suppl):S123–131. https://doi.org/10.1016/j.bbmt.2010.09.008

4. Dunogue B, Pilmis B, Mahlaoui N, Elie C, Coignard-Biehler H, Amazzough K, et al. Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France. Clin Infect Dis. 2017;64:767–75. https://doi.org/10.1093/cid/ciw837

5. Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA, et al. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. Biol Blood Marrow Transplant. 2012;18:1368–77. https://doi.org/10.1016/j.bbmt.2012.02.002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: The leopard sign as a potential characteristic of chronic granulomatous disease-associated colitis, unrelated to colitis severity;Frontiers in Immunology;2023-12-13

2. Transplantation using targeted busulfan for Diamond–Blackfan anemia;Pediatrics International;2023-01

3. Significance of therapeutic dose monitoring of busulfan and targeted dose adjustment in transplantation;Japanese Journal of Transplantation and Cellular Therapy;2023

4. Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance;CPT: Pharmacometrics & Systems Pharmacology;2022-06-16

5. Conditioning regimens for inborn errors of immunity: current perspectives and future strategies;International Journal of Hematology;2022-06-08